初级艾滋病毒预防的成本效益不断变化:直接影响的简单计算
Geoff P Garnett1, Joshua T Herbeck2, Adam Akullian2
1TB & HIV Team, Bill & Melinda Gates Foundation, Seattle, Washington, USA.
Journal of the International AIDS Society
|May 16, 2025
概括
撒哈拉以南非洲艾滋病毒发病率的下降降低了初级艾滋病毒预防的成本效益. 为了提高成本效益,预防必须针对高风险群体,或者降低成本.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 卫生经济学 卫生经济学
背景情况:
- 预防和治疗艾滋病毒已经减少了发病率,但需要新的工具来进一步控制.
- 传统的成本效益研究使用复杂的传输模型;更简单的分析也很有价值.
研究的目的:
- 开发简单的方程来计算艾滋病毒预防干预措施的成本效益,预算影响和流行病学影响.
- 分析艾滋病毒发病率下降如何影响初级艾滋病毒预防的成本效益.
主要方法:
- 介绍了成本效益,预算影响和流行病学影响计算的方程.
- 包括诸如多次干预,人口风险异质性,有效性,持续时间和成本等因素.
主要成果:
- 撒哈拉以南非洲艾滋病毒发病率下降使得初级艾滋病毒预防的成本效益降低.
- 为了防止一个艾滋病毒感染,需要覆盖的数量随着发病率下降而增加.
- 成本效益由发病率,疗效,持续时间和成本驱动;预算影响由成本,人口规模和覆盖范围决定.
结论:
- 简单的计算表明,艾滋病毒发病率下降会降低初级预防的成本效益.
- 为了提高成本效益,艾滋病毒预防干预措施应不成比例地被那些风险最高的人使用,或者变得更便宜.
- 目前的查工具可能无法充分区分针对性预防的风险.
相关概念视频
Retrovirus Life Cycles
45.4K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106


